John Winstanley

2.7k total citations
33 papers, 1.7k citations indexed

About

John Winstanley is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, John Winstanley has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in John Winstanley's work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (5 papers) and S100 Proteins and Annexins (5 papers). John Winstanley is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (5 papers) and S100 Proteins and Annexins (5 papers). John Winstanley collaborates with scholars based in United Kingdom, United States and Australia. John Winstanley's co-authors include Philip S. Rudland, Angela Platt‐Higgins, Roger Barraclough, Suzete de Silva Rudland, Sam Leinster, Christopher R. West, H Bishop, Rachel Howitt, Mohamed El‐Tanani and Christopher R. West and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Cell Science.

In The Last Decade

John Winstanley

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Winstanley United Kingdom 18 836 610 419 416 236 33 1.7k
Laura Boldrini Italy 27 1.2k 1.4× 916 1.5× 733 1.7× 652 1.6× 114 0.5× 98 2.5k
Colleen Wu United States 12 675 0.8× 469 0.8× 189 0.5× 535 1.3× 129 0.5× 19 1.3k
Thomas Zwingers Germany 16 386 0.5× 1.2k 1.9× 310 0.7× 446 1.1× 259 1.1× 30 2.2k
Svein A. Haukaas Norway 25 1.6k 1.9× 702 1.2× 984 2.3× 732 1.8× 67 0.3× 60 2.7k
Tim H. Brümmendorf Germany 22 753 0.9× 325 0.5× 219 0.5× 195 0.5× 279 1.2× 86 1.6k
Christian Kersting Germany 22 790 0.9× 440 0.7× 294 0.7× 295 0.7× 43 0.2× 42 1.6k
PR Carroll United States 7 611 0.7× 766 1.3× 659 1.6× 414 1.0× 54 0.2× 14 1.7k
Fabienne Baffert Switzerland 13 968 1.2× 434 0.7× 223 0.5× 341 0.8× 177 0.8× 19 1.5k
Michael Lahn United States 23 1.3k 1.6× 1.1k 1.9× 264 0.6× 400 1.0× 203 0.9× 42 2.2k
Rachelle W. Johnson United States 26 907 1.1× 1.0k 1.7× 198 0.5× 295 0.7× 65 0.3× 55 1.8k

Countries citing papers authored by John Winstanley

Since Specialization
Citations

This map shows the geographic impact of John Winstanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Winstanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Winstanley more than expected).

Fields of papers citing papers by John Winstanley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Winstanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Winstanley. The network helps show where John Winstanley may publish in the future.

Co-authorship network of co-authors of John Winstanley

This figure shows the co-authorship network connecting the top 25 collaborators of John Winstanley. A scholar is included among the top collaborators of John Winstanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Winstanley. John Winstanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rudland, Suzete de Silva, Angela Platt‐Higgins, John Winstanley, et al.. (2011). Statistical Association of Basal Cell Keratins with Metastasis-Inducing Proteins in a Prognostically Unfavorable Group of Sporadic Breast Cancers. American Journal Of Pathology. 179(2). 1061–1072. 17 indexed citations
2.
Rudland, Philip S., Angela Platt‐Higgins, Suzete de Silva Rudland, et al.. (2010). Significance of the Fanconi Anemia FANCD2 Protein in Sporadic and Metastatic Human Breast Cancer. American Journal Of Pathology. 176(6). 2935–2947. 30 indexed citations
3.
Barraclough, Dong L., Angela Platt‐Higgins, Suzete de Silva Rudland, et al.. (2009). The Metastasis-Associated Anterior Gradient 2 Protein Is Correlated with Poor Survival of Breast Cancer Patients. American Journal Of Pathology. 175(5). 1848–1857. 74 indexed citations
4.
Murray, N., et al.. (2009). Diagnosis and treatment of advanced breast cancer: summary of NICE guidance. BMJ. 338(feb25 1). b509–b509. 7 indexed citations
5.
Bishop, Hugh, et al.. (2008). Audit of Blood Transfusion in Elective Breast Cancer Surgery – Do We Need to Group and Save Pre-Operatively?. Annals of The Royal College of Surgeons of England. 90(6). 472–473. 16 indexed citations
6.
Jenkins, Valerie, Valerie Shilling, G.P. Deutsch, et al.. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer. 94(6). 828–834. 306 indexed citations
7.
Ainsworth, Paul, John Winstanley, Joyce Pearson, H Bishop, & David R. Garrod. (2004). Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma. European Journal of Cancer. 40(15). 2269–2273. 24 indexed citations
8.
Jones, A. S., Christopher Webb, John E. Fenton, et al.. (2001). A report of 50 patients with carcinoma of the hypopharynx treated by total pharyngolaryngo-oesophagectomy repaired by gastric transposition. Clinical Otolaryngology. 26(6). 447–451. 8 indexed citations
9.
Platt‐Higgins, Angela, Christine Renshaw, Christopher R. West, et al.. (2000). Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. International Journal of Cancer. 89(2). 198–208. 78 indexed citations
10.
Sibson, R., et al.. (2000). Variant estrogen receptor α mRNAs in human breast cancer specimens. International Journal of Cancer. 88(2). 209–216. 27 indexed citations
11.
Winstanley, John, et al.. (1999). Anaesthesia for Conn's syndrome. Anaesthesia. 54(6). 569–574. 15 indexed citations
12.
Taylor, Susan, Angela Platt‐Higgins, Philip S. Rudland, John Winstanley, & Roger Barraclough. (1998). Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens. International Journal of Cancer. 76(4). 459–463. 37 indexed citations
13.
Martín, L, et al.. (1997). Is a histological section representative of whole tumour vascularity in breast cancer?. British Journal of Cancer. 76(1). 40–43. 25 indexed citations
14.
Martín, L, Christine Renshaw, David Lowe, et al.. (1997). Examining the technique of angiogenesis assessment in invasive breast cancer. British Journal of Cancer. 76(8). 1046–1054. 105 indexed citations
15.
Winstanley, John, et al.. (1995). The value of guidelines in a breast screening service. European Journal of Surgical Oncology. 21(2). 140–142. 9 indexed citations
16.
Winstanley, John, et al.. (1994). Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. British Journal of Cancer. 69(4). 772–776. 76 indexed citations
17.
Rudland, Philip S., et al.. (1993). Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.. Journal of Histochemistry & Cytochemistry. 41(4). 543–553. 21 indexed citations
18.
Roberts, N B, John Dutton, Mary C. White, John Winstanley, & R A Sells. (1992). An Adrenaline-Secreting Ganglioneuroblastoma with Elevated Urinary HMMA but Normal Metanephrine Excretion. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 29(6). 678–680. 3 indexed citations
19.
Winstanley, John, et al.. (1991). The long term prognostic significance of c-erbB-2 in primary breast cancer. British Journal of Cancer. 63(3). 447–450. 186 indexed citations
20.
Winstanley, John, T Cooke, W.D. George, et al.. (1991). The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. British Journal of Cancer. 64(1). 99–101. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Boldrini Breakdown of academic impact, for papers by Colleen Wu Breakdown of academic impact, for papers by Thomas Zwingers Breakdown of academic impact, for papers by Svein A. Haukaas Breakdown of academic impact, for papers by Tim H. Brümmendorf Breakdown of academic impact, for papers by Christian Kersting Breakdown of academic impact, for papers by PR Carroll Breakdown of academic impact, for papers by Fabienne Baffert Breakdown of academic impact, for papers by Michael Lahn Breakdown of academic impact, for papers by Rachelle W. Johnson
Rankless by CCL
2026